DSD-T212

Congenital Adrenal Hyperplasia (CAH) · 46,XX · DSD-T212

DSD-T212 · Congenital Adrenal Hyperplasia (CAH) · 2021 · Automated translation

Genes CYP17A1 · Karyotype 46,XX · Phenotypes HPO:0000823, Delayed puberty (HP:0000823)

46,XY isolated 17,20-lyase deficiency caused by compound heterozygous CYB5A variants, with testicular microlithiasis.

Case fields and evidence

Category

Congenital Adrenal Hyperplasia (CAH)

Age

Neonatal onset, LC-MS/MS evaluation at age 17

Sex

Male (46,XY, ambiguous genitalia at birth)

Karyotype

46,XX

Genetics

CYP17A1

Phenotypes

Delayed puberty (HP:0000823)

Diagnosis

46,XY isolated 17,20-lyase deficiency caused by compound heterozygous CYB5A variants, with testicular microlithiasis.

Follow-up

At 3 months after discontinuation: testosterone 6.5 nmol/L, FSH 4.7 IU/L, LH 20.1 IU/L.

General phenotype

Male phenotype; primary hypogonadism.

Imaging

Testicular microlithiasis detected at 18 months of age; stable on ultrasound during childhood and puberty.

Laboratory findings

Neonatal hCG stimulation: testosterone <0.3→1.0 nmol/L, androstenedione 0.6→0.8 nmol/L; FSH <0.3 IU/L, LH 1.0 IU/L; at age 17 LC-MS/MS showed testosterone 6.1 nmol/L, androstenedione <0.8 nmol/L, DHEAS 738 nmol/L, 17-OHP 30.8 nmol/L; MetHb 0.098 mmol/mmol Hb.

Management

Testosterone therapy and hypospadias repair during infancy; intramuscular testosterone from age 13; replacement resumed at age 16 after gynecomastia developed following discontinuation.

Pathology

Not reported in the original text (no testicular biopsy performed).

Evidence level

See source

Clinical history

See source

Family history

See source

Puberty / Tanner

See source

Cite this resource

DSD Research Library | Congenital Adrenal Hyperplasia (CAH) · 46,XX · DSD-T212 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T212?version=v1.4.0